Event JSON
{
"id": "b111060244aefb908ad81fe392ed2d0748466866b3bd22b112bb01c070f29b9c",
"pubkey": "862c45018b00bd3adf89c229a13cb1d3f58d702998d84e111ca36b4d75d7abd0",
"created_at": 1726607564,
"kind": 1,
"tags": [
[
"t",
"Biotech \u0026 Health"
],
[
"t",
"Government \u0026 Policy"
],
[
"t",
"blindsight"
],
[
"t",
"Elon Musk"
],
[
"t",
"Neuralink"
],
[
"proxy",
"https://techcrunch.com/feed/#https%3A%2F%2Ftechcrunch.com%2F2024%2F09%2F17%2Fneuralinks-breakthrough-device-clearance-from-fda-does-not-mean-they-have-cured-blindness%2F",
"rss"
]
],
"content": "Neuralink’s ‘breakthrough device’ clearance from FDA does not mean they have cured blindness\n\nNeuralink, the Elon Musk-owned brain-computer interface company, has received “breakthrough device” clearance from the FDA. But this does not mean they have developed a cure for blindness, whatever Musk might say. The breakthrough devices program at the FDA is a voluntary program that developers can apply to that, if granted, “offers manufacturers an opportunity to […]\n© 2024 TechCrunch. All rights reserved. For personal use only.\n\n\nhttps://techcrunch.com/2024/09/17/neuralinks-breakthrough-device-clearance-from-fda-does-not-mean-they-have-cured-blindness/",
"sig": "93637dfd079f009532ba45493f66a7d9e2b9d11233b89fd95a531ffa5ef5a6a47691a7fa0a9e02cadbf9db7fb98d9689e33a0b43dc20dfd8b31d1d19c4653879"
}